<p><b>OBJECTIVE</b>To observe the differences in clinical effect on menstrual
migraine between subgaleal
acupoint injection with
metoclopramide and
oral administration of medication.</p><p><b>
METHODS</b>Sixty-four
patients of menstrual
migraine were randomized into a subgaleal
acupoint injection group and a medication group, 32 cases in each one. In the subgaleal
acupoint injection group, the
acupoint injection started 10 days before
menstruation. Eight
acupoints on the
head were selected and injected alternatively in two groups, once every 2 days, 4
treatments made one session and 3 sessions (3
menstrual cycles) were required. In the medication group,
flunarizine was applied with
oral administration, 2.5 mg each
time, once every night. The
duration of treatment was 3 months. The
analgesic effect, frequency and
time of
pain attack were observed in 3 and 6 months
after treatment in the two groups.</p><p><b>RESULTS</b>
After treatment, VAS scores were lower than those before
treatment in the two groups (P<0.01, P<0.05), the attack frequency and
pain time were all reduced as compared with those before
treatment (all P<0.01).
After treatment, VAS score, the frequency and
time of
pain attack in the subgaleal
acupoint injection group were improved significantly as compared with the medication group (all P<0.01).</p><p><b>CONCLUSION</b>The subgaleal
acupoint injection with
metoclopramide achieves the superior preventive effect in clinical
treatment of menstrual
migraine as compared with
flunarizine.</p>